Small Cell Carcinoma of the Prostate

• CLINICAL_TRIALS trial_result · 2025-10-20
  Clinical Trial Update: A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. [Phase 1, Phase 2]

  A Phase 1/2 trial evaluating BXCL701 in combination with pembrolizumab for metastatic castration-resistant prostate cancer with small cell n…

• CLINICAL_TRIALS research · 2025-07-22
  Clinical Trial Update: ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer [Phase 2]

  This is a Phase 2 clinical trial evaluating ZEN-3694 in combination with enzalutamide and pembrolizumab for metastatic castration-resistant …

• CLINICAL_TRIALS trial_result · 2025-06-10
  Clinical Trial Update: Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate [Phase 1]

  Phase 1 trial evaluating pembrolizumab with chemotherapy for locally advanced or metastatic small cell and neuroendocrine cancers of the uro…